Holdings of Ally Bridge Group (NY) LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 18 in 3 countries
- Top ten
- 73.5 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Praxis Precision Medicines Inc | 32,810 | 10.6M $ | |
| 2 | Minerva Neurosciences Inc | 1,655,500 | 10M $ | |
| 3 | Soleno Therapeutics Inc | 200,000 | 6.7M $ | |
| 4 | Ovid therapeutics Inc | 2,818,459 | 6.3M $ | |
| 5 | COMPASS PATHWAYS PLC | 1,045,000 | 5.8M $ | |
| 6 | TARSUS PHARMACEUTICALS INC | 80,859 | 5.7M $ | |
| 7 | Solid Biosciences Inc | 766,974 | 5.5M $ | |
| 8 | Edgewise Therapeutics Inc | 161,000 | 5.1M $ | |
| 9 | CYTOMX THERAPEUTICS INC | 900,000 | 4.2M $ | |
| 10 | INVENTIVA SA | 745,300 | 4.1M $ | |
| 11 | Perspective Therapeutics Inc | 926,557 | 3.9M $ | |
| 12 | ABIVAX SA | 33,712 | 3.8M $ | |
| 13 | ALUMIS INC | 166,959 | 3.7M $ | |
| 14 | Capricor Therapeutics Inc | 113,899 | 3.5M $ | |
| 15 | Whitehawk Therapeutics Inc | 817,939 | 2.8M $ | |
| 16 | Inhibikase Therapeutics Inc | 1,325,000 | 2.2M $ | |
| 17 | AN2 Therapeutics Inc | 526,315 | 1.8M $ | |
| 18 | Relmada Therapeutics Inc | 210,525 | 1.5M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 84.3 %
- France 9.1 %
- United Kingdom 6.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 15 | 73.3M $ | 84.28 % |
| 2 | France | 2 | 7.9M $ | 9.07 % |
| 3 | United Kingdom | 1 | 5.8M $ | 6.64 % |
Cite this page
Titelia. "Holdings of Ally Bridge Group (NY) LLC". https://titelia.com/en/funds/US13F1822947